Stock PDSB PDS BIOTECHNOLOGY CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News PDS Biotechnology Corporation

Equities

PDSB

US70465T1079

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-19 pm EDT 		5-day change 1st Jan Change
2.645 USD -8.79% Intraday chart for PDS Biotechnology Corporation -17.08% -46.78%
Mar. 28 B. Riley Securities Adjusts PDS Biotechnology's Price Target to $11 From $14, Maintains Buy Rating MT
Mar. 27 Empire Metals targets key milestones in Australia AN

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
B. Riley Securities Adjusts PDS Biotechnology's Price Target to $11 From $14, Maintains Buy Rating
MT
PDS Biotech Announces Clinical Strategy Update and Reports Full Year 2023 Financial Results
AQ
Empire Metals targets key milestones in Australia
AN
Transcript : PDS Biotechnology Corporation, 2023 Earnings Call, Mar 27, 2024
PDS Biotech Announces Clinical Strategy Update and Reports Full Year 2023 Financial Results
AQ
PDS Biotechnology Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
North American Morning Briefing : Stocks Edge -2-
DJ
PDS Biotechnology Announces Conference Call and Webcast for Business Update and Full Year 2023 Financial Results
AQ
PDS Biotech Announces Publication of Preclinical Research and Grant of U.S. Composition of Matter Patent for Infectimune®
AQ
PDS Biotechnology : Biotech Announces Publication of Preclinical Research and Grant of U.S. Composition of Matter Patent for Infectimune® - Form 8-K
PU
PDS Biotechnology Corporation Announces Publication of Preclinical Research
CI
PDS Biotechnology Names Kirk Shepard as Chief Medical Officer
MT
PDS Biotech Announces Retirement of Lauren V. Wood, M.D., and Appointment of Kirk V. Shepard, M.D., as Chief Medical Officer
AQ
PDS Biotechnology Corporation Announces Executive Changes
CI
PDS Biotech to Participate at B. Riley Securities 4th Annual Oncology Conference
AQ
PDS Biotechnology Reports Inducement Grant under Nasdaq Listing Rule 5635(4)
AQ
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
AQ
Apyx Medical Names Matthew Hill as CFO
MT
PDS Biotechnology Appoints Lars Boesgaard as Finance Chief
MT
PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PDSB Stock
  4. News PDS Biotechnology Corporation